April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention ...

By Julie Steenhuysen, Siddhi Mahatole and Mariam Sunny May 1 (Reuters) - Moderna surpassed Wall Street estimates for ...

In the first quarter of 2026, Moderna reported revenue of US$389 million versus US$108 million a year earlier, while net loss ...

The company is making up for a decline in U.S. vaccine sales with better results elsewhere, continuing a turnaround that’s ...

CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...

Moderna reported a more than threefold jump in sales to $389 million for the first quarter, driven by international Covid vaccine sales under long-term government partnerships. The Cambridge, Mass., ...

LOS ANGELES - Moderna announced on Thursday that it is currently developing a vaccine that combines a COVID-19 booster as well as a seasonal flu shot. "Today we are announcing the first step in our ...

Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a head-to-head trial assessing the tolerability of the two COVID vaccines. In the phase ...

The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is no ...

Older adults across the European Union are a step closer to replacing two annual jabs with one. In late February 2026, the ...